Iso-glucuronides

Current Drug Metabolism

Volumn 12, Issue 3, 2011, Pages 222-228

  Dickinson, Ronald G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acyl glucuronides; Acyl migration; Anomerization; Carboxylate drugs; Chemical reactivity; Covalent binding; Isomers; Rearrangement; Toxicity

Indexed keywords

DIFLUNISAL; GLUCURONIDE; ISO GLUCURONIDE; NAPROXEN; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; DRUG ABSORPTION; DRUG BINDING; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; HUMAN; IN VITRO STUDY; ISOMER; NONHUMAN; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANIMALS; GLUCURONIDES; HUMANS; ISOMERISM; KINETICS; PROTEIN BINDING; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79953645989     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795101796     Document Type: Article

References (65)

1. Faed, E.M. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev., 1984, 15, 1213-1249. (Pubitemid 15158041)
2. Spahn-Langguth, H.; Benet, L.Z. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev., 1992, 24, 5-47.
3. Fenselau, C. Acyl glucuronides as chemically reactive intermediates. In: Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity, F.C. Kaufman, Ed.; Springer-Verlag; Berlin, 1994, pp. 367-389.
4. Boelsterli, U.A. Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions. Curr. Drug Metab., 2002, 3, 439-450. (Pubitemid 34778006)
5. Bailey, M.J.; Dickinson, R.G. Acyl glucuronide reactivity in perspective: biological consequences. Chem.-Biol. Interact., 2003, 145, 117-137. (Pubitemid 36398426)
6. Shipkova, M.; Armstrong, V.W.; Oellerich, M.; Wieland, E. Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther. Drug Monit, 2003, 25, 1-16. (Pubitemid 36139819)
7. Fischer, E. Migration of the acyl in glycerides. Chem. Ber., 1920, 53, 1621-1633.
8. Haines, A.M. Relative reactivities of hydroxyl groups in carbohydrates. Adv. Carbohydr. Chem. Biochem. 1976, 33, 11-109.
9. Faed, E.M.; McQueen, E.G. Separation of two conjugates of clofibric acid (CPIB) found in the urine of subjects taking clofibrate. Clin. Exp. Pharmacol. Physiol., 1978, 5, 195-198. (Pubitemid 9034884)
10. Compernolle, F.; Van Hees, G.P.; Blanckaert, N.; Hairwegh K.P. Glucuronic acid conjugates of bilirubin-IXalpha in normal bile compared with post-obstructive bile. Transformation of the 1-Oacyl glucuronide into 2-, 3-, and 4-O-acyl glucuronides. Biochem. J., 1978, 171, 185-201. (Pubitemid 8373586)
11. Blanckaert, N.; Compernolle, F.; Leroy, P.; van Houtte J.; Fevery, J.; Hairwegh, K.P. The fate of bilirubin-IXalpha glucuronide in cholestasis and during storage in vitro. Intramolecular rearrangement to positional Isomers of glucuronic acid. Biochem. J., 1978, 171, 203-214. (Pubitemid 8373587)
12. van Breemen, R.B.; Fenselau, C. Acylation of albumin by 1-O-acyl glucuronides. Drug Metab. Dispos., 1985, 13, 318-320. (Pubitemid 15009448)
13. Smith, P.C.; McDonagh, A.F.; Benet, L.Z. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J. Clin. Invest., 1986, 77, 934-939. (Pubitemid 16067967)
14. Smith, P.C.; Benet, L.Z.; McDonagh, A.F. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug Metab. Dispos., 1990, 18, 639-644. (Pubitemid 20348852)
15. Vanderhoeven, S.J.; Lindon, J.C.; Troke, J.; Nicholson, J.K.; Wilson, J.D. NMR spectroscopic studies of the transacylation reactivity of ibuprofen 1-beta-O-acyl glucuronide. J. Pharm. Biomed. Anal., 2006, 41, 1002-1006.
16. Akira, K.; Hasegawa, H.; Shinohara, Y.; Imachi, M.; Hashimoto, T. Stereoselective internal acyl migration of 1-beta-O-acyl glucuronides of enantiomeric 2-phenylpropionic acids. Biol. Pharm. Bull., 2000, 23, 506-510. (Pubitemid 30241826)
17. Illing, H.P.; Wilson, I.D. pH dependent formation of betaglucuronidase resistant conjugates from the biosynthetic ester glucuronide of isoxepac. Biochem. Pharmacol., 1981, 30, 3381-3384. (Pubitemid 12248351)
18. Williams, A.M.; Worrall, S.; De Jersey, J.; Dickinson, R.G. Studies on the reactivity of acyl glucuronides - III. Glucuronide -derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans. Biochem. Pharmacol., 1992, 43, 745-755.
19. Wen, Z.; Stern, S.T.; Martin, D.E.; Lee, K.H.; Smith, P.C. Structural characterization of anti-HIV candidate PA-457 [3-O-(3,3- dimethylsuccinyl)- betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma. Drug Metab. Dispos., 2006, 34, 1436-1442. (Pubitemid 44285382)
20. Akira, K.; Taira, T.; Hasegawa, H.; Sakuma, C.; Shinohara, Y. Studies on the stereoselective internal migration of ketoprofen glucuronides using 13C labeling and nuclear magnetic resonance spectroscopy. Drug Metab. Dispos., 1998, 26, 457-464. (Pubitemid 28223886)
21. Skordi, E.; Wilson, I.D.; Lindon, J.C.; Nicholson, J.K. Kinetic studies on the intramolecular acyl migration of beta-1-O-acyl glucuronides: application to the glucuronides of (R)- and (S)- ketoprofen, (R)- and (S)-hydroxy-ketoprofen metabolites, and tolmetin by 1H-NMR spectroscopy. Xenobiotica, 2005, 35, 715-725. (Pubitemid 41441521)
22. Giroud, Y.; Carrapt, P.-A.; Pagliara, A.; Testa, B.; Dickinson, R.G. Intrinsic and intramolecular lipophilicity effects in O-glucuronides. Helv. Chim. Acta, 1998, 81, 330-341.
23. Dickinson, R.G.; King, A.R. Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Ther. Drug Monit., 1989, 11, 712-720. (Pubitemid 19267407)
24. Hansen-Moller, J.; Cornett, C.; Dalgaard, L.; Hansen, S.H. Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronide. J. Pharm. Biomed. Anal., 1988, 6, 229-240.
25. Mizuma, T.; Benet, L.Z.; Lin, E.T. High-performance liquid chromatographic determination and identification of acyl migration and photodegradation products of furosemide 1-O-acyl glucuronide. J. Chromatogr. B. Biomed. Sci. Appl., 1998, 718, 153-162. (Pubitemid 28477588)
26. Xue, X.J.; Simmons, N.J.; Unger, S.E.; Anderson, D.F.; Jenkins, R.G. Separation of a BMS drug candidate and acyl glucuronide from seven glucuronide positional isomers in rat plasma via highperformance liquid chromatography with tandem mass spectrometry detection. Rapid Commun. Mass Spectrom., 2006, 20, 1776-1786. (Pubitemid 43793882)
27. Xue, X.J.; Akinsanya, J.B.; Raghavan, N.; Zhang, D. Optimization to eliminate the interference of migration isomers for measuring 1- O beta-acyl glucuronide without extensive chromatographic separation. Rapid Commun. Mass Spectrom., 2008, 22, 109-120. (Pubitemid 351156122)
28. Sidelmann, U.G.; Lenz, E.M.; Spraul, M.; Hoffman, M.; Troke, J.; Sanderson, P.N.; Lindon, J.C.; Wilson, I.D.; Nicholson, J.K. 750 MHz HPLC-NMR spectroscopic studies on the separation and characterization of the positional isomers of the glucuronides of 6,11-dihydro-11-oxdibenz[b,e]oxepin-2-acetic acid. Anal. Chem., 1996, 68, 106-110.
29. Mortensen, R.W.; Corcoran, O.; Cornett, C.; Sidelmann, U.G.; Lindon, J.C.; Nicholson, J.K.; Hansen, S.H. S-naproxen-beta-1-Oacyl glucuronide degradation kinetics by stopped-flow highperformance liquid chromatography-1H NMR and highperformance liquid chromatography-UV. Drug Metab. Dispos., 2001, 29, 375-380. (Pubitemid 32275549)
30. Mortensen, R.W.; Corcoran, O.; Cornett, C.; Sidelmann, U.G.; Troke, J.; Lindon, J.C.; Nicholson, J.K.; Hansen, S.H. LC-1H NMR used for determination of the elution order of S-naproxen glucuronide isomers in two isocratic reversed-phase LC-systems. J. Pharm. Biomed. Anal., 2001, 24, 477-485. (Pubitemid 32121974)
31. Corcoran, O.; Mortensen, R.W.; Hansen, S.H.; Troke, J.; Nicholson, J.K. HPLC/1H NMR spectroscopic studies of the reactive alpha- 1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide. Chem. Res. Toxicol., 2001, 14, 1363-1370. (Pubitemid 32983261)
32. Benet, L.Z.; Spahn-Langguth, H.; Iwakawa H.; Volland, C.; Mizuma, T.; Mayer, S.; Mutchler, E.; Lin, E.T. Predictability of the covalent binding of acidic drugs in man. Life Sci., 1993, 53, 141-146.
33. Sidelmann, U.; Hansen, S.H.; Gavaghan, C.; Nicholls, A.W.; Carless, H.A., Lindon, J.C.; Wilson, I.D.; Nicholson, J.K. Development of a simple liquid chromatographic method for the separation of mixtures of positional isomers and anomers of synthetic 2-, 3- and 4-fluorobenzoic acid glucuronides formed via acyl migration. J. Chromatogr. B. Biomed. Appl., 1996, 685, 113-122. (Pubitemid 26371121)
34. Nicholls, A.W.; Akira, K.; Lindon, J.C.; Farrant, R.D.; Wilsin, I.D.; Harding, J.; Killick, D.A.; Nicholson, J.K. NMR spectroscopic and theoretical chemistry studies on the internal acyl migration reactions of the 1-O-alpha-beta-D glucopyranuronate conjugates of 2-, 3- and 4-(trifluoromethyl) benzoic acids. Chem. Res. Toxicol., 1996, 9, 1414-1424. (Pubitemid 26403850)
35. Vanderhoeven, S.J.; Lindon, J.C.; Troke, J.; Tranter, G.E.; Wilson, I.D.; Nicholson, J.K. NMR and QSAR studies on the transacylation reactivity of model 1beta-O-acyl glucuronides. I: design, synthesis and degradation rate measurement. Xenobiotica, 2004, 34, 73-85. (Pubitemid 38187064)
36. Vanderhoeven, S.J.; Troke, L.; Tranter, G.E.; Wilson, I.D.; Nicholson, J.K.; Lindon, J.C. Nuclear magnetic resonance (NMR) and quantitative structure-activity relationship (QSAR) studies on the transacylation reactivity of model 1beta-O-acyl glucuronides. II: QSAR modeling of the reaction using both computational and experimental NMR parameters. Xenobiotica, 2004, 34, 889-900. (Pubitemid 39648168)
37. Johnson, C.H.; Wilson, I.D.; Harding, J.R.; Stachulski, A.V.; Nicholson, J.K.; Lindon, J.C. NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of ibuprofen ((+/-)-(R,S)-2-(4- isobutlyphenyl)propanoic acid), its metabolites, and analogues. Anal. Chem., 2007, 79, 8720-878727.
38. Walker, G.S.; Atherton, J.; Bauman, J.; Kohl, C.; Lam, W.; Reilly, M.; Lou, Z.; Mutlib, A. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy. Chem. Res. Toxicol., 2007, 20, 876-886. (Pubitemid 47035341)
39. Wang, J.; Davis, M.; Li, F.; Azam, F.; Scatina, J.; Talaat, R. A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements. Chem. Res. Toxicol., 2004, 17, 1206-1216. (Pubitemid 39265876)
40. Baba, A.; Yoshioka, T. Structure-activity relationships for degradation reaction of 1-beta-O-acyl glucuronides: Kinetic description and prediction of intrinsic electrophilic reactivity under physiological conditions. Chem. Res. Toxicol., 2009, 22, 158-172.
41. King, A.R.; Dickinson, R.G. Studies on the reactivity of acyl glucuronides - I: Phenolic glucuronidation of isomers of diflunisal acyl glucuronide in the rat. Biochem. Pharmacol., 1991, 42, 2289-2299.
42. Munafo, A.; McDonagh, A.F.; Smith, P.C.; Benet, L.Z. Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro. Pharm. Res., 1990, 7, 21-27. (Pubitemid 20115793)
43. Ding, A.; Ojingwa, J.C.; McDonagh, A.F.; Burlingame, A.; Benet, L.Z. Evidence for covalent binding of acyl glucuronide via an imine mechanism as revealed by tandem mass spectrometry. Proc. Natl. Acad. Sci. USA, 1993, 90, 3797-3801. (Pubitemid 23134112)
44. Grubb, N.; Weill, A.; Caldwell, J. Studies on the in vitro reactivity of clofibryl and fenofibryl glucuronides. Evidence for protein binding via a Schiff's base mechanism. Biochem. Pharmacol., 1993, 46, 357-364. (Pubitemid 23239984)
45. Kretz-Rommel, A.; Boelsterli, U.A. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct. Drug Metab. Dispos., 1994, 22, 956-961. (Pubitemid 24377373)
46. Ding, A.; Zia-Amirhosseini, P.; McDonagh, A.F.; Burlingame, A.L.; Benet, L.Z. Reactivity of tolmetin glucuronide with human serum akbumin. Identification of binding sites and mechanisms by tandem mass spectrometry. Drug Metab. Dispos., 1995, 23, 369-376.
47. Qui, Y.; Burlingame, A.L.; Benet, L.Z. Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies by tandem mass spectrometry. Drug Metab. Dispos., 1998, 26, 246-256. (Pubitemid 28182401)
48. Iwaki, M.; Ogiso, T.; Inagawa, S.; Kakehi, K. In vitro regioselective stability of beta-1-O-and 2-O-acyl glucuronides of naproxen and their covalent binding to human serum albumin. J. Pharm. Sci., 1999, 88, 52-57. (Pubitemid 29037368)
49. McKinnon, G.E.; Dickinson, R.G. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. Res. Comm. Chem. Pathol. Pharmacol., 1989, 66, 339-354. (Pubitemid 20014409)
50. Dickinson, R.G.; Kluck, R.M.; Eadie, M.J.; Hooper, W.D. Disposition of β-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis. J.Pharmacol. Exp. Ther., 1985, 233, 214-221. (Pubitemid 15083548)
51. Williams, A.M.; Dickinson, R.G. Studies on the reactivity of acyl glucuronides - VI: Modulation of reversible and covalent interaction of diflunisal acyl glucuronide and its isomers with human plasma protein in vitro. Biochem. Pharmacol., 1994, 47, 457-467.
52. Dickinson, R.G.; King, A.R. Rearrangement of diflunisal acyl glucuronide into its β-glucuronidase-resistant isomers facilitates transport through the small intestine to the colon of the rat. Life Sci., 2001, 70, 25-36. (Pubitemid 33124354)
53. Boudinot, F.D.; Homon, C.A.; Jusko, W.J.; Ruelius, H.W. Protein binding of oxazepam and its glucuronide conjugates to human albumin. Biochem. Pharmacol., 1985, 34, 2115-2121. (Pubitemid 15017071)
54. Ojingwa, J.C.; Spahn-Langguth, H.; Benet, L.Z. Reversible binding of tolmetin, zomepirac, and their acyl glucuronides to human serum albumin and plasma. J. Pharmacokinet. Biopharm., 1994, 22, 19-40. (Pubitemid 24153353)
55. Ruelius, H.W.; Kirkman, S.K.; Young, E.M., Janssen, F.W. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. Adv. Exp. Med. Biol., 1986, 197, 431-441.
56. Mizuma, T.; Benet, L.Z.; Lin, E.T. Interaction of human serum albumin with furosemide glucuronide: a role of albumin in isomerization, hydrolysis, reversible binding and irreversible binding of a 1-O-acyl glucuronide metabolite. Biopharm. Drug Dispos., 1999, 20, 131-136. (Pubitemid 29137670)
57. Smith, P.C.; McDonagh, A.F.; Benet, L.Z. Effect of esterase inhibition on the disposition of zomepirac glucuronide and its covalent binding to plasma proteins in the guinea pig. J. Pharmacol. Exp. Ther., 1990, 252, 218-224. (Pubitemid 20067716)
58. Dickinson, R.G.; Kluck, R.M.; Wood, B.T.; Eadie, M.J.; Hooper, W.D. Impaired biliary elimination of β-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers. Drug Metab. Dispos., 1986, 14, 255-262. (Pubitemid 16105483)
59. Dickinson, R.G.; King, A.R. Studies on the reactivity of acyl glucuronides - II: Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. Biochem. Pharmacol., 1991, 42, 2301-2306.
60. Jaggi, R.; Addison, R.S., King, A.R.; Suthers, B.D.; Dickinson, R.G. Conjugation of desmethylnaproxen in the rat - a novel acyl glucuronide-sulfate diconjugate as a major biliary metabolite. Drug Metab. Dispos., 2002, 30. 161-172.
61. Josephy, P.D.; Guengerich, F.P.; Miners, J.O. "Phase I" and "Phase II" drug metabolism: terminology that we should phase out? Drug Metab. Rev., 2005, 37, 575-580. (Pubitemid 43068148)
62. Kumar, S.; Samuel, K.; Subramanian; R.; Braun, M.P.; Stearns, R.A.; Chiu, S.H.; Evans, D.C.; Baillie, T.A. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. J. Pharmacol. Exp. Ther., 2002, 303, 969-978. (Pubitemid 35424378)
63. Seitz, S.; Kretz-Rommel, A.; Oude Elferink, R.P.; Boelsterli, U.A. Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular export pump (Mrp2). Chem. Res. Toxicol., 1998, 11, 513-519. (Pubitemid 28242496)
64. Wright, A.W.E.; Dickinson, R.G. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat. J. Pharmacol. Exp. Ther., 2004, 310, 584-588. (Pubitemid 38988903)
65. Lagas, J.S.; Sparidans, R.W.; Wagenaar, E.; Beijnen, J.H.; Schinkel, A.H. Hepatic clearance of reactive glucuronides of diclofenac in the mouse is dependant on multiple ATP-binding cassette efflux transporters. Mol. Pharmacol., 2010, 77, 687-694.